260 related articles for article (PubMed ID: 16400651)
1. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
Latini DM; Elkin EP; Cooperberg MR; Sadetsky N; Duchane J; Carroll PR
Cancer; 2006 Feb; 106(4):789-95. PubMed ID: 16400651
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
3. Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison.
Ritch CR; Morrison BF; Hruby G; Coard KC; Mayhew R; Aiken W; Benson MC; McKiernan JM
BJU Int; 2013 Apr; 111(4 Pt B):E186-90. PubMed ID: 23107067
[TBL] [Abstract][Full Text] [Related]
4. Postprostatectomy cancer-free survival of African Americans is similar to non-African Americans after adjustment for baseline cancer severity.
Underwood W; Wei J; Rubin MA; Montie JE; Resh J; Sanda MG
Urol Oncol; 2004; 22(1):20-4. PubMed ID: 14969799
[TBL] [Abstract][Full Text] [Related]
5. Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Population.
Lichtensztajn DY; Leppert JT; Brooks JD; Shah SA; Sieh W; Chung BI; Gomez SL; Cheng I
J Natl Compr Canc Netw; 2018 Nov; 16(11):1353-1360. PubMed ID: 30442735
[No Abstract] [Full Text] [Related]
6. Racial Variation in Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Results from the CEASAR Study.
Tyson MD; Alvarez J; Koyama T; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen VW; Penson DF; Barocas DA
Eur Urol; 2017 Aug; 72(2):307-314. PubMed ID: 27816300
[TBL] [Abstract][Full Text] [Related]
7. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-up.
Faisal FA; Sundi D; Cooper JL; Humphreys EB; Partin AW; Han M; Ross AE; Schaeffer EM
Urology; 2014 Dec; 84(6):1434-41. PubMed ID: 25432835
[TBL] [Abstract][Full Text] [Related]
9. Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate.
Cross CK; Shultz D; Malkowicz SB; Huang WC; Whittington R; Tomaszewski JE; Renshaw AA; Richie JP; D'Amico AV
J Clin Oncol; 2002 Jun; 20(12):2863-8. PubMed ID: 12065563
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy.
Rosser CJ; Kuban DA; Levy LB; Pettaway CA; Chichakli R; Kamat AM; Sanchez-Ortiz RF; Pisters LL
J Urol; 2003 Nov; 170(5):1856-9. PubMed ID: 14532792
[TBL] [Abstract][Full Text] [Related]
11. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
[TBL] [Abstract][Full Text] [Related]
13. Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratification.
Chinea FM; Lyapichev K; Epstein JI; Kwon D; Smith PT; Pollack A; Cote RJ; Kryvenko ON
Oncotarget; 2017 Mar; 8(13):20802-20812. PubMed ID: 28160549
[TBL] [Abstract][Full Text] [Related]
14. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
[TBL] [Abstract][Full Text] [Related]
15. Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy.
Leapman MS; Freedland SJ; Aronson WJ; Kane CJ; Terris MK; Walker K; Amling CL; Carroll PR; Cooperberg MR
J Urol; 2016 Nov; 196(5):1408-1414. PubMed ID: 27352635
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.
Zagars GK; Pollack A; Pettaway CA
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):517-23. PubMed ID: 9806509
[TBL] [Abstract][Full Text] [Related]
17. Racial/Ethnic Disparities in Tumor Characteristics and Treatments in Favorable and Unfavorable Intermediate Risk Prostate Cancer.
Wenzel M; Nocera L; Collà Ruvolo C; Würnschimmel C; Tian Z; Shariat SF; Saad F; Briganti A; Tilki D; Graefen M; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
J Urol; 2021 Jul; 206(1):69-79. PubMed ID: 33683934
[TBL] [Abstract][Full Text] [Related]
18. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life for men with prostate cancer--an evaluation of outcomes 12-24 months after treatment.
Brassell SA; Elsamanoudi SI; Cullen J; Williams ME; McLeod DG
Urol Oncol; 2013 Nov; 31(8):1504-10. PubMed ID: 22608541
[TBL] [Abstract][Full Text] [Related]
20. Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
Caire AA; Sun L; Polascik TJ; Albala DM; Moul JW
BJU Int; 2010 Oct; 106(8):1157-60. PubMed ID: 20367635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
